Kematian kedua di Kanada selepas terima vaksin AstraZeneca

OTTAWA: Wilayah Alberta di Kanada merekodkan kematian pertama akibat pembekuan darah yang jarang berlaku selepas menerima vaksin Covid-19 AstraZeneca, yang disahkan ketua pegawai perubatannya semalam.

Kes di Alberta itu adalah yang kedua membabitkan pembekuan darah dan satu-satunya kematian selepas lebih 253,000 dos vaksin AstraZeneca diberikan kepada penduduk di wilayah berkenaan.

AstraZeneca bagaimanapun tidak memberi maklum balas segera kepada Reuters.

Bulan lalu, wilayah Quebec melaporkan kematian pertama di Kanada, selepas seorang pesakit menerima vaksin AstraZeneca.

Komplikasi yang jarang berlaku itu, yang sesetengah pengawal selia, termasuk Health Canada gelarnya sebagai “prothrombotic immune thrombocytopenia”, melibatkan pembekuan darah dengan jumlah platelet rendah, sel dalam darah yang membantunya membeku.

The Canadian province of Alberta reported its first death of a patient from a rare blood clot condition after receiving the AstraZeneca (AZN.L) COVID-19 vaccine, its chief medical officer said.

Canada has reported at least five cases of blood clots following immunization with the vaccine, but public health officials maintain the benefits of the AstraZeneca shot outweigh the potential risks.

The Alberta case, of a woman in her 50s, marks the second case of blood clots, and the only death after more than 253,000 doses of AstraZeneca were administered in the province, Alberta’s chief medical officer of health Dr. Deena Hinshaw said in a statementon Tuesday.

“While any death is tragic, it is important to remember that the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine,” Hinshaw said.